NCT06863792

Brief Summary

ChatGPT provides quick access to information, research support, and study materials, but concerns remain regarding its reliability, accuracy, and inability to offer personalized care principles essential in nursing. Although previous studies show its high accuracy in clinical responses, over-reliance on AI-generated medical information necessitates cautious use. The study will explore both the benefits and limitations of ChatGPT in nursing education, particularly in hypertension learning.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 7, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

March 10, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 10, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2025

Completed
Last Updated

March 7, 2025

Status Verified

March 1, 2025

Enrollment Period

1 month

First QC Date

February 26, 2025

Last Update Submit

March 3, 2025

Conditions

Keywords

nursing studentsartificial intelligenceHypertensionnursing education

Outcome Measures

Primary Outcomes (3)

  • Hypertension Prevention Attitudes Scale

    The scale consists of 26 items and subdimensions, including protection and control, habits and lifestyle, nutrition attitudes, mental state and physical activity, and disease and risk knowledge. The items are rated on a five-point Likert scale, ranging from "Strongly Disagree" to "Strongly Agree." The scale scores can range from 26 to 130. There is a positive relationship between the scale scores and attitudes toward hypertension prevention. The Cronbach's alpha value of the scale is 0.91.

    At the beginning of the study first admission.

  • Artificial Intelligence Anxiety Scale

    The Artificial Intelligence Anxiety Scale (AIAS) was developed by Wang and Wang (2019) and adapted into Turkish by Akkaya et al. (2021). The scale is a 5-point Likert type, consisting of 21 items and 4 factors. These factors are: Learning, Job Change, Socio-technical Blindness, and Artificial Intelligence Structuring. The minimum score that can be obtained from the scale is 21, and the maximum score is 105. A higher score indicates a higher level of AI anxiety. The Cronbach's alpha coefficient of the scale is reported to be 0.95.

    Immediately after the intervention (answering the scale questions)

  • Cognitive Load Scale

    The scale developed by Paas and Van Merriënboer (1993) aims to measure the cognitive load of students during individual study processes. It was adapted into Turkish by Kılıç and Karadeniz (2004). The scale is a symmetric, Likert-type scale with scores ranging from 1 to 9. It allows the assessment of the effort a student exerts during their individual learning process. According to the scale, cognitive load increases from 1 to 9. Scores between 1-4 are considered low cognitive load, while scores between 5-9 are considered high cognitive load. Paas and Van Merriënboer (1993) reported an internal consistency coefficient of 0.82 for the scale, while Kılıç and Karadeniz (2004) calculated an internal consistency coefficient of 0.90 for the Turkish version.

    Immediately after the intervention (answering the scale questions)

Study Arms (2)

ChatGPT Group

EXPERIMENTAL

Students in the intervention group will answer the questions from the Hypertension Prevention Attitude Scale using ChatGPT.

Other: ChatGPT

Control Group

NO INTERVENTION

In the control group students will respond Hypertension Prevention Attitude Scale using traditional methods.

Interventions

ChatGPTOTHER

Students in the intervention group will answer the questions from the Hypertension Prevention Attitude Scale using ChatGPT.

Also known as: Control Group
ChatGPT Group

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • To be enrolled in the nursing program at a private university, during the 2024-2025 academic year.
  • To have taken the Internal Medicine Nursing course (In this course, students receive 4 hours of theoretical lessons on nursing care for hypertension patients).
  • To be willing to volunteer for participation in the study.

You may not qualify if:

  • Students who wish to withdraw from the research at any stage will not be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • Alkhaqani, A. L. (2023). Can ChatGPT help researchers with scientific research writing. Journal of Medical Research and Reviews, 1(1), 9-12. https://doi.org/10.5455/JMRR.20230626013424

    BACKGROUND
  • Branum C, Schiavenato M. Can ChatGPT Accurately Answer a PICOT Question? Assessing AI Response to a Clinical Question. Nurse Educ. 2023 Sep-Oct 01;48(5):231-233. doi: 10.1097/NNE.0000000000001436. Epub 2023 Apr 28.

    PMID: 37130197BACKGROUND
  • Abdulai AF, Hung L. Will ChatGPT undermine ethical values in nursing education, research, and practice? Nurs Inq. 2023 Jul;30(3):e12556. doi: 10.1111/nin.12556. Epub 2023 Apr 26. No abstract available.

    PMID: 37101311BACKGROUND
  • Goktas, P., Kucukkaya, A., & Karacay, P. (2024). Utilizing GPT 4.0 with prompt learning in nursing education: A case study approach based on Benner's theory. Teaching and Learning in Nursing, 19(2), e358-e367.

    BACKGROUND
  • Sallam M. ChatGPT Utility in Healthcare Education, Research, and Practice: Systematic Review on the Promising Perspectives and Valid Concerns. Healthcare (Basel). 2023 Mar 19;11(6):887. doi: 10.3390/healthcare11060887.

    PMID: 36981544BACKGROUND
  • Wang, Y. Y. & Wang, Y. S. (2019). Development and validation of an artificial intelligence anxiety scale: an initial application in predicting motivated learning behavior. Interactive Learning Environments, 1-16. https://doi.org/10.1080/10494820.2019.1674887

    BACKGROUND

MeSH Terms

Conditions

Hypertension

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Nursemin UNAL, Assoc. Prof.

    Ankara University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nursemin Unal, Assoc. Prof.

CONTACT

Nilay Bektaş Akpınar, Assist.Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessor blind
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Students will be randomly assigned to the intervention (ChatGPT) and control groups in a 1:1 allocation ratio. Group assignments will be determined using a computer-based randomization table, with 48 students in the intervention group and 48 in the control group, placed in separate classrooms. Students in the intervention group will answer the questions from the Hypertension Prevention Attitude Scale using ChatGPT, while those in the control group will respond using traditional methods.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 26, 2025

First Posted

March 7, 2025

Study Start

March 10, 2025

Primary Completion

April 10, 2025

Study Completion

May 10, 2025

Last Updated

March 7, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share